Nationwide Recall of Eye Products Due to Safety Concerns

WASHINGTON — Several over-the-counter eye products used to treat dry and irritated eyes have been recalled after the U.S. Food and Drug Administration (FDA) raised concerns about product safety. The recall was initiated by AvKARE, a pharmaceutical distributor, following an audit that uncovered manufacturing deviations.

The recall notice on AvKARE’s website states that while the specific health risks associated with the affected products are unclear, “deviations may lead to products of unacceptable quality,” and it is impossible to rule out potential risks to consumers. The FDA has categorized this recall as a Class II risk, which indicates a possibility of temporary health consequences.

The recalled products were distributed between May 26, 2023, and April 21, 2025, with expiration dates ranging from April 2025 to March 2027. AvKARE advises consumers to stop using these products immediately.

To facilitate the return process, consumers can fill out a form available on AvKARE’s website and submit it via fax or email. Once the form is processed, AvKARE will provide a Return Authorization Form. The company has assured that full credit, including shipping costs, will be issued for returned items.

AvKARE expressed regret for any inconvenience caused by this recall. They encouraged those affected to reach out with any concerns regarding the products in question.

Consumers are urged to check the FDA website for detailed information about the recall and the specific products involved.